Activity value 77
International Buyer&Supplier, the last transaction date was
2025-10-28Address: corporate campussarkhej-dholka road, bhtahmedabad-382210 india
The above chart presents the market trend analysis for cadila pharmaceuticals ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 2568 transactions, with a transaction quantity of 867225245.23 and a transaction weight of 378411.39.
YearTransactionsQuantityWeight
Bill of lading data
<
1/15
>
Trade date
2025/10/28
B/L No.
nxgwamddeb91256
Supplier
cadila pharmaceuticals ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2025/10/13
B/L No.
nxgwamdddm81443
Supplier
cadila pharmaceuticals ltd.
Buyers
eversana life science services llc
Product description
MEDICAMENTS (EXCLUDING GOODS OF HEADING . , . OR . ) CONSISTING OF MIXED OR UNMI XED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC Expand
Trade date
2025/09/30
B/L No.
107575670310
Supplier
cadila pharmaceuticals ltd.
Buyers
công ty cổ phần xuất nhập khẩu y tế thành phố hồ chí minh
Supplier
cadila pharmaceuticals ltd.
Buyers
công ty tnhh allegens
POLs
——
PODs
——
Supply area
India
Purchas area
Vietnam
Weight
——
Amount
264768
Hs code
30049099
Product tags
haljab premix
Product description
ThuốcTrị loét dạ dày: Rabicad 20 (Rabeprazol sodium 20mg). Hộp lớn chứa 10 Hộp x1 vỉ x 10 Viên; viên nén bao tan trong ruột. SĐK:890110003224. Lô: AR185015B; AR18E5014; SX:14.08.2025; HD:13.08.2027;
Expand
Trade date
2025/09/15
B/L No.
61826709561
Supplier
cadila pharmaceuticals ltd.
Buyers
ambica international
cadila pharmaceuticals ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as bat,pharmaceutical raw material,r pharm.
According to the 52wmb.com global trade database, as of 2025-10-28, the company has completed 47089 international trades,
with its main trading regions covering ethiopia,sri lanka,other etc.
The core products include HS30049099,HS30049039,HS30049079 etc,
often transported via ahemdabad icd insbi6,port ahemdabad air acc inamd4, port mundra etc,
and its main trading partners are .cadila pharmaceuticals ethiop,sunshine heathcare lanka ltd.,life care suppliers pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on cadila pharmaceuticals ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.